Skip to main content
SpringerLink
Log in

Management of the Hospitalized Patient with Inflammatory and Stricturing Crohn’s Disease

  • Chapter
  • First Online:
Management of Inpatient Inflammatory Bowel Disease

  • 552 Accesses

Abstract

Crohn’s disease is a chronic inflammatory condition with significant impact on quality of life and can be associated with complications such as abscesses, fistula, and strictures. A proportion of patients require hospitalization for severe inflammatory disease or for complications related to stricturing including bowel obstruction. Early recognition and appropriate management can reduce the risk of associated morbidity. As such, this chapter will review the clinical presentation, diagnosis, and management of hospitalized patients with inflammatory and stricturing Crohn’s disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lewis JD, Gelfand JM, Troxel AB, Forde KA, Newcomb C, Kim H, et al. Immunosuppressant medications and mortality in inflammatory bowel disease. Am J Gastroenterol. 2008;103:1428–36.

    Article  CAS  PubMed  Google Scholar 

  2. Peyrin-Biroulet L, Loftus EV Jr, Colombel J-F, Sandborn WJ. The natural history of adult Crohn’s disease in population-based cohorts. Am J Gastroenterol. 2010;105:289–97.

    Article  PubMed  Google Scholar 

  3. Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, et al. Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis. 2002;8:244–50.

    Article  PubMed  Google Scholar 

  4. Bernstein CN, Loftus EV Jr, Ng SC, Lakatos PL, Moum B. Epidemiology, hospitalizations and surgery in Crohn’s disease. Gut. 2012;61:622–9.

    Article  PubMed  Google Scholar 

  5. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Hansel SL, McCurdy JD, Barlow JM, Fidler J, Fletcher JG, Becker B, et al. Clinical benefit of capsule endoscopy in Crohn’s disease: impact on patient management and prevalence of proximal small bowel involvement. Inflamm Bowel Dis. 2018;24:1582–8.

    Article  PubMed  Google Scholar 

  7. Rieder F, Lawrance IC, Leite A, Sans M. Predictors of fibrostenotic Crohn’s disease. Inflamm Bowel Dis. 2011;17:2000–7.

    Article  PubMed  Google Scholar 

  8. Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, et al. Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001;49:777–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Rieder F, Zimmermann EM, Remzi FH, Sandborn WJ. Crohn’s disease complicated by strictures: a systematic review. Gut. 2013;62:1072–84.

    Article  CAS  PubMed  Google Scholar 

  10. Rahman A, Jairath V, Feagan BG, Khanna R, Shariff SZ, Allen BN, et al. Declining hospitalization and surgical intervention rates in patients with Crohn’s disease: a population-based cohort. Aliment Pharmacol Ther. 2019;50:1086–93.

    Article  PubMed  Google Scholar 

  11. Frolkis AD, Dykeman J, Negrón ME, Debruyn J, Jette N, Fiest KM, et al. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology. 2013;145:996–1006.

    Article  Google Scholar 

  12. Rieder F, Fiocchi C. Mechanisms of tissue remodeling in inflammatory bowel disease. Dig Dis. 2013;31:186–93.

    Article  PubMed  Google Scholar 

  13. Rieder F, Fiocchi C, Rogler G. Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases. Gastroenterology. 2017;152:340–50.

    Article  PubMed  Google Scholar 

  14. Loly C, Belaiche J, Louis E. Predictors of severe Crohn’s disease. Scand J Gastroenterol. 2008;43:948–54.

    Article  CAS  PubMed  Google Scholar 

  15. Bettenworth D, Rieder F. Medical therapy of stricturing Crohn’s disease: what the gut can learn from other organs – a systematic review. Fibrogenesis Tissue Repair. 2014;7:5.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Lian L, Stocchi L, Remzi FH, Shen B. Comparison of endoscopic dilation vs surgery for anastomotic stricture in patients with Crohn’s disease following ileocolonic resection. Clin Gastroenterol Hepatol. 2017;15:1226–31.

    Article  PubMed  Google Scholar 

  17. Bouhnik Y, Carbonnel F, Laharie D, Stefanescu C, Hebuteme X, Abitbol V, et al. Efficacy of adalimumab in patients with Crohn’s disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study. Gut. 2018;67:53–60.

    Article  CAS  PubMed  Google Scholar 

  18. Murthy SK, Begum J, Benchimol EI, Bernstein CN, Kaplan GG, McCurdy JD, et al. Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study. Gut. 2020;69:274–82.

    Article  CAS  PubMed  Google Scholar 

  19. Perler B, Ungaro R, Baird G, Maliette M, Bright R, Shah S, et al. Presenting symptoms in inflammatory bowel disease: descriptive analysis of a community-based inception cohort. BMC Gastroenterol. 2019;19:47.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Burgmann T, Clara I, Graff L, Walker J, Lix L, Rawsthorne P, et al. The Manitoba inflammatory bowel disease cohort study: prolonged symptoms before diagnosis – how much is irritable bowel syndrome. Clin Gastroenterol Hepatol. 2006;4:614–20.

    Article  PubMed  Google Scholar 

  21. Pellino G, Nicolai E, Catalano OA, Campione S, D'Amineto FP, Salvatore M, et al. PET/MR versus PET/CT imaging: impact on the clinical Management of small-bowel Crohn’s disease. J Crohns Colitis. 2016;10:277–85.

    Article  PubMed  Google Scholar 

  22. Berg DF, Bahadursingh AM, Kaminski DL, Longo WE. Acute surgical emergencies in inflammatory bowel disease. Am J Surg. 2002;184:45–51.

    Article  PubMed  Google Scholar 

  23. Chang S, Malter L, Hudesman D. Disease monitoring in inflammatory bowel disease. World J Gastroenterol. 2015;21:11246–59.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Khanna S, Shin A, Kelly CP. Management of Clostridium difficile infection in inflammatory bowel disease: expert review from the clinical practice updates committee of the AGA Institute. Clin Gastroenterol Hepatol. 2017;15:166–74.

    Article  PubMed  Google Scholar 

  25. Zittan E, Kelly OB, Gralnek IM, Silverberg MS, Hillary SA. Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn’s disease activity. JGH Open. 2018;2:201–6.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Low RN, Francis IR, Politoske D, Bennett M. Crohn’s disease evaluation: comparison of contrast-enhanced MR imaging and single-phase helical CT scanning. J Magn Reson Imaging. 2000;11:127–35.

    Article  CAS  PubMed  Google Scholar 

  27. Balthazar EJ. CT of the gastrointestinal tract: principles and interpretation. AJR Am J Roentgenol. 1991;156:23–32.

    Article  CAS  PubMed  Google Scholar 

  28. Lee SS, Ha HK, Yang SK, Kim AY, Kim TK, Kim PN, et al. CT of prominent pericolic or perienteric vasculature in patients with Crohn’s disease: correlation with clinical disease activity and findings on barium studies. AJR Am J Roentgenol. 2002;179:1029–36.

    Article  PubMed  Google Scholar 

  29. Calabrese E, Maaser C, Zorzi F, Kannengiesser K, Hanauer SB, Bruining DH, et al. Bowel ultrasonography in the management of Crohn’s disease. A review with recommendations of an international panel of experts. Inflamm Bowel Dis. 2016;22:1168–83.

    Article  PubMed  Google Scholar 

  30. Rigazio C, Ercole E, Laudi C, Daperno M, Lavagna A, Crocella L, et al. Abdominal bowel ultrasound can predict the risk of surgery in Crohn’s disease: proposal of an ultrasonographic score. Scand J Gastroenterol. 2009;44:585–93.

    Article  PubMed  Google Scholar 

  31. Silva AC, Pimenta M, Guimaraes LS. Small bowel obstruction: what to look for. Radiographics. 2009;29:423–39.

    Article  PubMed  Google Scholar 

  32. Maglinte DD, Gage SN, Harmon BH, Kelvin FM, Hage FP, Chua GT, et al. Obstruction of the small intestine: accuracy and role of CT in diagnosis. Radiology. 1993;188:61–4.

    Article  CAS  PubMed  Google Scholar 

  33. Fukuya T, Hawes DR, Lu CC, Chang PJ, Barloon TJ. CT diagnosis of small-bowel obstruction: efficacy in 60 patients. AJR Am J Roentgenol. 1992;158:765–72.

    Article  CAS  PubMed  Google Scholar 

  34. Mayo-Smith WW, Wittenberg J, Bennett GL, Gervais DA, Gazelle GS, Mueller PR. The CT small bowel faeces sign: description and clinical significance. Clin Radiol. 1995;50:765–7.

    Article  CAS  PubMed  Google Scholar 

  35. Maglinte DDT, Heitkamp DE, Howard TJ, Kelvin FM, Lappas JC. Current concepts in imaging of small bowel obstruction. Radiol Clin N Am. 2003;41:263–vi.

    Article  PubMed  Google Scholar 

  36. Baker SR. ACR appropriateness criteria on small-bowel obstruction: a critique of the term and its terms. J Am Coll Radiol. 2007;4:443–5.

    Article  PubMed  Google Scholar 

  37. Lu C, Holubar SD, Rieder F. How I approach the management of stricturing Crohn’s disease. Am J Gastroenterol. 2019;114:1181–4.

    Article  PubMed  Google Scholar 

  38. Maconi G, Carsana L, Fociani P, Sampietro GM, Ardizzone S, et al. Small bowel stenosis in Crohn’s disease: clinical, biochemical and ultrasonographic evaluation of histological features. Aliment Pharmacol Ther. 2003;18:749–56.

    Article  CAS  PubMed  Google Scholar 

  39. Kumar S, Hakim A, Alexakis C, Chhaya V, Tzias D, Pilcher J, et al. Small intestinal contrast ultrasonography for the detection of small bowel complications in Crohn’s disease: correlation with intraoperative findings and magnetic resonance enterography. J Gastroenterol Hepatol. 2015;30:86–91.

    Article  PubMed  Google Scholar 

  40. Vogel J, da Luz MA, Baker M, Hammel J, Einstein D, Stocci L, et al. CT enterography for Crohn’s disease: accurate preoperative diagnostic imaging. Dis Colon Rectum. 2007;50:1761–9.

    Article  PubMed  Google Scholar 

  41. Pous-Serrano S, Frasson M, Palasi Gimenez R, Sanchez-Jorda G, Pamies-Guilabert J, et al. Accuracy of magnetic resonance enterography in the preoperative assessment of patients with Crohn’s disease of the small bowel. Color Dis. 2017;19:126–33.

    Article  Google Scholar 

  42. Adler J, Punglia DR, Dillman JR, Polydorides AD, Dave M, Al-HAwary MM, et al. Computed tomography enterography findings correlate with tissue inflammation, not fibrosis in resected small bowel Crohn’s disease. Inflamm Bowel Dis. 2012;18:849–56.

    Article  PubMed  Google Scholar 

  43. Bettenworth D, Bokemeyer A, Baker M, Mao R, Parker CE, Nguyen T, et al. Assessment of Crohn’s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review. Gut. 2019;68:1115–26.

    Article  CAS  PubMed  Google Scholar 

  44. Ripolles T, Rausell N, Paredes JM, Grau E, Martinez MJ, Vizuete J. Effectiveness of contrast-enhanced ultrasound for characterization of intestinal inflammation in Crohn’s disease: a comparison with surgical histopathology analysis. J Crohns Colitis. 2013;7:120–8.

    Article  PubMed  Google Scholar 

  45. Chiorean MV, Sandrasegaran K, Saxena R, Maglinte DD, Nakeeb A, Johnson CS. Correlation of CT enteroclysis with surgical pathology in Crohn’s disease. Am J Gastroenterol. 2007;102:2541–50.

    Article  PubMed  Google Scholar 

  46. Rimola J, Plannel N, Rodriguez S, Delgado S, Ordas I, Ramirez-Morros A, et al. Characterization of inflammation and fibrosis in Crohn’s disease lesions by magnetic resonance imaging. Am J Gastroenterol. 2015;110:432–40.

    Article  PubMed  Google Scholar 

  47. Li XH, Mao R, Huang SY, Sun CH, Cao QH, Fang ZN, et al. Characterization of degree of intestinal fibrosis in patients with Crohn disease by using magnetization transfer MR imaging. Radiology. 2018;287:494–503.

    Article  PubMed  Google Scholar 

  48. Lei DK, Ollech JE, Andersen M, Weisshof R, Zmeter N, Sossenheimer P, et al. Long-duration oral vancomycin to treat Clostridioides difficile in patients with inflammatory bowel disease is associated with a Low rate of recurrence. Am J Gastroenterol. 2019;114:1904–8.

    Article  PubMed  Google Scholar 

  49. Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG clinical guideline: management of Crohn’s disease in adults. Am J Gastroenterol. 2018;113:481–517.

    Article  PubMed  Google Scholar 

  50. Benchimol EI, Seow CH, Steinhart AH, Griffiths AM. Traditional corticosteroids for induction of remission in Crohn’s disease. Cochrane Database Syst Rev. 2008;2008:CD006792.

    PubMed Central  Google Scholar 

  51. Chun A, Chadi RM, Korelitz BI, Colonna T, Felder JB, Jackson MH, et al. Intravenous corticotrophin vs. hydrocortisone in the treatment of hospitalized patients with Crohn’s disease: a randomized double-blind study and follow-up. Inflamm Bowel Dis. 1998;4:177–81.

    Article  CAS  PubMed  Google Scholar 

  52. Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, et al. Maintenance infliximab for Crohn’s disease: the ACCENT I randomized trial. Lancet. 2002;359:1541–9.

    Article  CAS  PubMed  Google Scholar 

  53. Kawalec P, Mikrut A, Wiśniewska N, Pilc A. Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn’s disease: systematic review and meta-analysis. Arch Med Sci. 2013;9:765–79.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Akobeng AK, Zachos M. Tumor necrosis factor-alpha antibody for induction of remission in Crohn’s disease. Cochrane Database Syst Rev. 2004:CD003574.

    Google Scholar 

  55. Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, et al. Infliximab, azathioprine, or combination therapy for Crohn’s disease. N Engl J Med. 2010;362:1383–95.

    Article  CAS  PubMed  Google Scholar 

  56. Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, et al. Vedolizumab as induction and maintenance therapy for Crohn’s disease. N Engl J Med. 2013;369:711–21.

    Article  CAS  PubMed  Google Scholar 

  57. Feagan BG, Sandborn WJ, Gasink C, Jacobstein D, Lang Y, Friedman JR, et al. Ustekinumab as induction and maintenance therapy for Crohn’s disease. N Engl J Med. 2016;375:1946–60.

    Article  CAS  PubMed  Google Scholar 

  58. Guo S-B, Duan Z-J. Decompression of the small bowel by endoscopic long-tube placement. World J Gastroenterol. 2012;18:1822–6.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Forbes A, Escher J, Hébuterne X, Klek S, Krznaric Z, Schneider S, et al. ESPEN guideline: clinical nutrition in inflammatory bowel disease. Clin Nutr. 2017;36:321–47.

    Article  PubMed  Google Scholar 

  60. Nguyen GC, Munsell M, Harris ML. Nationwide prevalence and prognostic significance of clinically diagnosable protein-calorie malnutrition in hospitalized inflammatory bowel disease patients. Inflamm Bowel Dis. 2008;14:1105–11.

    Article  PubMed  Google Scholar 

  61. Wedlake L, Slack N, Andreyev HJN, Whelan K. Fiber in the treatment and maintenance of inflammatory bowel disease: a systematic review of randomized controlled trials. Inflamm Bowel Dis. 2014;20:576–86.

    Article  PubMed  Google Scholar 

  62. Adamina M, Gerasimidis K, Sigall-Boneh R, Zmora O, de Buck van Overstraeten A, et al. Perioperative dietary therapy in inflammatory bowel disease. J Crohns Colitis. 2021;14(4):431–44.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Mount Sinai Hospital, Department of Medicine, University of Toronto, Toronto, ON, Canada

    Parul Tandon & Adam V. Weizman

Authors
  1. Parul Tandon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adam V. Weizman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adam V. Weizman .

Editor information

Editors and Affiliations

  1. Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA

    Joseph D. Feuerstein

  2. Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA

    Adam S. Cheifetz

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tandon, P., Weizman, A.V. (2022). Management of the Hospitalized Patient with Inflammatory and Stricturing Crohn’s Disease. In: Feuerstein, J.D., Cheifetz, A.S. (eds) Management of Inpatient Inflammatory Bowel Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-0716-1987-2_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-1987-2_5

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-0716-1986-5

  • Online ISBN: 978-1-0716-1987-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation